Nomura holdings inc (NMR)
Balance Sheet / Quarterly
Sep'11Mar'11Sep'10Mar'10
ASSETS
Cash and cash deposits:
Cash and cash equivalents

7,160

19,579

6,404

10,928

Time deposits

6,579

4,101

2,933

2,108

Deposits with stock exchanges and other segregated cash

2,915

2,304

1,976

1,442

Total cash and cash deposits

16,654

25,984

11,313

14,478

Loans and receivables:
Loans receivable (including /554,137 million and /601,864 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

13,332

15,361

13,522

14,030

Receivables from customers (including /13 million and /8,634 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

673

396

503

633

Receivables from other than customers

11,902

11,221

8,718

7,576

Allowance for doubtful accounts

63

59

50

58

Total loans and receivables

25,844

26,919

22,693

22,181

Collateralized agreements:
Securities purchased under agreements to resell (including /1,186,096 million and /800,535 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

115,337

115,498

96,963

75,738

Securities borrowed

72,248

67,638

73,225

57,744

Total collateralized agreements

187,585

183,136

170,188

133,482

Trading assets and private equity investments:
Trading assets (including securities pledged as collateral of 4,621,042 million and 5,474,813 million ($71,065 million) as of March 31, 2011 and September 30, 2011, respectively; including 15,444 million and 18,412 million ($239 million) measured at fair value by applying fair value option as of March 31, 2011 and September 30, 2011, respectively)

198,305

180,673

181,157

153,898

Private equity investments (including 62,553 million and 56,511 million ($734 million) measured at fair value by applying fair value option as of March 31, 2011 and September 30, 2011, respectively)

3,379

3,497

3,716

3,493

Total trading assets and private equity investments

201,684

184,170

184,873

157,391

Other assets:
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of /397,834 million and /423,552 million as of March 31, 2018 and September 30, 2018, respectively)

13,691

4,737

4,638

3,824

Non-trading debt securities

11,094

7,151

5,707

3,306

Investments in equity securities

1,052

1,100

1,258

1,316

Investments in and advances to affiliated companies

2,630

3,300

2,969

2,690

Other (including /176,029 million and /179,039 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

19,201

6,869

6,948

6,412

Total other assets

47,668

23,157

21,520

17,548

Total assets

479,435

443,366

410,587

345,080

LIABILITIES AND EQUITY
Short-term borrowings (including /372,188 million and /408,344 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

15,533

14,102

14,047

13,936

Payables and deposits:
Payables to customers

10,241

10,638

5,760

7,551

Payables to other than customers

7,986

4,962

4,912

4,010

Deposits received at banks

12,100

9,818

8,246

4,803

Total payables and deposits

30,327

25,418

18,918

16,364

Collateralized financing:
Securities sold under agreements to repurchase (including /435,905 million and /218,154 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

140,902

130,665

114,199

86,488

Securities loaned (including /133,375 million and /136,454 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

22,947

20,664

20,353

19,443

Other secured borrowings

16,782

14,046

15,063

14,160

Total collateralized financing

180,631

165,375

149,615

120,091

Trading liabilities

96,664

104,990

102,657

89,473

Other liabilities (including /25,482 million and /18,788 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

12,607

6,673

5,086

5,301

Long-term borrowings (including /2,857,835 million and /3,140,801 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively)

113,632

101,534

95,594

77,078

Total liabilities

449,394

418,092

385,917

322,243

Commitments and contingencies (Note 22)

0

-

-

-

Equity:
Common stock
No par value shares; Authorized-6,000,000,000 shares as of March 31, 2018 and September 30, 2018, Issued-3,643,562,601 shares as of March 31, 2018 and September 30, 2018, Outstanding-3,392,937,486 shares as of March 31, 2018 and 3,382,481,612 shares as of September 30, 2018

7,717

7,183

7,117

6,365

Additional paid-in capital

8,889

7,810

7,641

6,808

Retained earnings

13,322

12,921

12,671

11,501

Accumulated other comprehensive income

-2,166

-1,567

-1,685

-1,169

Total NHI shareholder's equity before treasury stock

27,762

26,347

25,744

23,505

Common stock held in treasury, at cost-250,625,115 shares as of March 31, 2018 and 261,080,989 shares as of September 30, 2018

1,314

1,181

1,183

733

Total NHI shareholders' equity

26,448

25,166

24,561

22,772

Noncontrolling interests

3,593

108

109

65

Total equity

30,041

25,274

24,670

22,837

Total liabilities and equity

479,435

443,366

410,587

345,080